Florian Schnappauf
Florian Schnappauf is Vice President of Enterprise Commercial Strategy at Veeva Europe. He works with customers, partners, and product management to further Veeva’s Commercial Cloud solutions for the European market and help the industry speed medicines to patients. Prior to joining Veeva, Florian served as associate partner at McKinsey & Company focused on life sciences, and within other strategy and consulting roles at Airbus Defence & Space, Otto & Company Strategy Consultants, and Siemens.
Florian Schnappauf is Vice President of Enterprise Commercial Strategy at Veeva Europe. He works with customers, partners, and product management to further Veeva’s Commercial Cloud solutions for the European market and help the industry speed medicines to patients. Prior to joining Veeva, Florian served as associate partner at McKinsey & Company focused on life sciences, and within other strategy and consulting roles at Airbus Defence & Space, Otto & Company Strategy Consultants, and Siemens.
Articles: Florian Schnappauf
How Today’s Specialty Medicines are Driving the Future of Engagement
Global / The rise of niche therapies is shaping a more tailored engagement model, driven by data and AI, writes Florian Schnappauf, vice president of enterprise commercial strategy at Veeva Europe. Last year, orphan drugs accounted for more than a third of Europe’s new drug approvals, and the number of gene therapies more than doubled. Launches…
Latest Report
